Last reviewed · How we verify
Low-Molecular-Weight Heparins Calcium Injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Low-Molecular-Weight Heparins Calcium Injection (Low-Molecular-Weight Heparins Calcium Injection) — Capital Institute of Pediatrics, China.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Low-Molecular-Weight Heparins Calcium Injection TARGET | Low-Molecular-Weight Heparins Calcium Injection | Capital Institute of Pediatrics, China | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Low-Molecular-Weight Heparins Calcium Injection CI watch — RSS
- Low-Molecular-Weight Heparins Calcium Injection CI watch — Atom
- Low-Molecular-Weight Heparins Calcium Injection CI watch — JSON
- Low-Molecular-Weight Heparins Calcium Injection alone — RSS
Cite this brief
Drug Landscape (2026). Low-Molecular-Weight Heparins Calcium Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/low-molecular-weight-heparins-calcium-injection. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab